Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
Aged
Alleles
Diabetes Mellitus, Type 2
/ drug therapy
Drug Hypersensitivity
/ genetics
Equilibrative Nucleoside Transport Proteins
/ genetics
Female
Gastrointestinal Diseases
/ chemically induced
Genetic Association Studies
Humans
Hypoglycemic Agents
/ adverse effects
Male
Metformin
/ adverse effects
Middle Aged
Organic Cation Transporter 1
/ genetics
Polymorphism, Single Nucleotide
Risk Factors
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
19
10
2018
accepted:
11
02
2019
pubmed:
20
3
2019
medline:
26
3
2020
entrez:
20
3
2019
Statut:
ppublish
Résumé
Gastrointestinal adverse effects occur in 20-30% of patients with metformin-treated type 2 diabetes, leading to premature discontinuation in 5-10% of the cases. Gastrointestinal intolerance may reflect localized high concentrations of metformin in the gut. We hypothesized that reduced transport of metformin via the plasma membrane monoamine transporter (PMAT) and organic cation transporter 1 (OCT1) could increase the risk of severe gastrointestinal adverse effects. The study included 286 severe metformin-intolerant and 1,128 metformin-tolerant individuals from the IMI DIRECT (Innovative Medicines Initiative: DIabetes REsearCh on patient straTification) consortium. We assessed the association of patient characteristics, concomitant medication, and the burden of mutations in the Women ( These results suggest that intestinal metformin transporters and concomitant medications play an important role in the gastrointestinal adverse effects of metformin.
Identifiants
pubmed: 30885951
pii: dc18-2182
doi: 10.2337/dc18-2182
doi:
Substances chimiques
Equilibrative Nucleoside Transport Proteins
0
Hypoglycemic Agents
0
Organic Cation Transporter 1
0
SLC29A4 protein, human
0
Metformin
9100L32L2N
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1027-1033Subventions
Organisme : Wellcome Trust
ID : 102820/Z/13/Z
Pays : United Kingdom
Investigateurs
C Jennison
(C)
B Ehrhardt
(B)
P Baum
(P)
C Schoelsch
(C)
J I Freijer
(JI)
R Grempler
(R)
U Graefe-Mody
(U)
A M Hennige
(AM)
C Dings
(C)
T Lehr
(T)
N Scherer
(N)
I Sihinecich
(I)
F Pattou
(F)
V Raverdi
(V)
R Caiazzo
(R)
F Torres
(F)
H Verkindt
(H)
A Mari
(A)
A Tura
(A)
T Giorgino
(T)
R Bizzotto
(R)
P Froguel
(P)
A Bonneford
(A)
M Canouil
(M)
V Dhennin
(V)
C A Brorsson
(CA)
S Brunak
(S)
F De Masi
(F)
V Gudmundsdóttir
(V)
H K Pedersen
(HK)
K Banasik
(K)
E Thomas
(E)
W Sackett
(W)
H Staerfeldt
(H)
A T Lundgaard
(AT)
B Nilsson
(B)
A M Nielsen
(AM)
G Mazzoni
(G)
T Karaderi
(T)
S Rasmussen
(S)
J Johansen
(J)
R L Allesøe
(RL)
A Fritsche
(A)
B Thorand
(B)
J Adamski
(J)
H Grallert
(H)
M Haid
(M)
S Sharma
(S)
M Troll
(M)
J Adam
(J)
J Ferrer
(J)
P Froguel
(P)
R G Eriksen
(RG)
G Frost
(G)
R Haussler
(R)
M-G Hong
(MG)
J M Schwenk
(JM)
M Uhlen
(M)
C Nicolay
(C)
I Pavo
(I)
B Steckel-Hamann
(B)
M K Thomas
(MK)
K Adragni
(K)
H Wu
(H)
L M 't Hart
(LM)
R C Roderick
(RC)
N van Leeuwen
(N)
K F Dekkers
(KF)
F Frau
(F)
J Gassenhuber
(J)
B Jablonka
(B)
P Musholt
(P)
H Ruetten
(H)
J Tillner
(J)
T Baltauss
(T)
O Bernard
(O)
N Poenaru
(N)
M de Preville
(M)
M Rodriquez
(M)
K H Arumugam
(KH)
L Allin
(L)
T Engelbrechtsen
(T)
T H Hansen
(TH)
A Hansen
(A)
A Forman
(A)
O Jonsson
(O)
A Pedersen
(A)
J K Dutta
(JK)
H Vogt
(H)
M Vestergaard
(M)
T Laakso
(T)
T Kokkola
(T)
P W Kuulasmaa
(PW)
G N Franks
(GN)
H Giordano
(H)
H Pomares-Millan
(H)
P Fitipaldi
(P)
M Mutie
(M)
M Klintenberg
(M)
L Bergstrom
(L)
M Groop
(M)
N Ridderstrale
(N)
H A Atabaki Pasdar
(HA)
A J Deshmukh
(AJ)
D Heggie
(D)
D Wake
(D)
I McEvoy
(I)
M McVittie
(M)
A T Walker
(AT)
A V Hattersley
(AV)
A G Hill
(AG)
T J Jones
(TJ)
M H McDonald
(MH)
R Perry
(R)
M Nice
(M)
C E Hudson
(CE)
E T Thorne
(ET)
A Dermitzakis
(A)
L Viñuela
(L)
H Cabrelli
(H)
A Y Loftus
(AY)
L Dawed
(L)
I M Donnelly
(IM)
E R Forgie
(ER)
C N Pearson
(CN)
A A Palmer
(AA)
R W Brown
(RW)
A Koivula
(A)
M Wesolowska-Andersen
(M)
N Abdalla
(N)
J McRobert
(J)
J Fernandez
(J)
M Kaye
(M)
A Mourby
(A)
M I Mahajan
(MI)
N McCarthy
(N)
H Shah
(H)
Y Teare
(Y)
N Jiao
(N)
S Robertson
(S)
R W Gough
(RW)
A D Holl
(AD)
F Koopman
(F)
J W Rutters
(JW)
L Beulens
(L)
A D Groeneveld
(AD)
J D Koopman
(JD)
E L Bell
(EL)
None Thomas
B Whitcher
(B)
Informations de copyright
© 2019 by the American Diabetes Association.